View in EDS

Transcriptional mediators of treatment resistance in lethal prostate cancer.

Saved in:
Bibliographic Details
Title: Transcriptional mediators of treatment resistance in lethal prostate cancer.
Authors: He MX; Harvard Graduate Program in Biophysics, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Cuoco MS; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Crowdis J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Bosma-Moody A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, University of Massachusetts Memorial Medical Center, Worcester, MA, USA., Bi K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Kanodia A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Su MJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ku SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Garcia MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sweet AR; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Rodman C; Broad Institute of Harvard and MIT, Cambridge, MA, USA., DelloStritto L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA., Silver R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Steinharter J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shah P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Izar B; Columbia Center for Translational Immunology, New York, NY, USA.; Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center, New York, NY, USA., Walk NC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Burke KP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA., Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Tewari AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Camp SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Vokes NI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Thoracic/Head and Neck Oncology, MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA., Salari K; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Urology, Massachusetts General Hospital, Boston, MA, USA., Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Vigneau S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA., Fong L; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, USA., Russo JW; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Yuan X; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Balk SP; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rozenblatt-Rosen O; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Regev A; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Biology, Howard Hughes Medical Institute and Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Genentech, South San Francisco, CA, USA., Rotem A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.; AstraZeneca, Waltham, MA, USA., Taplin ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu.; Broad Institute of Harvard and MIT, Cambridge, MA, USA. eliezerm_vanallen@dfci.harvard.edu.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu.
Source: Nature medicine [Nat Med] 2021 Mar; Vol. 27 (3), pp. 426-433. Date of Electronic Publication: 2021 Mar 04.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33664492
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Transcriptional mediators of treatment resistance in lethal prostate cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22He+MX%22">He MX</searchLink>; Harvard Graduate Program in Biophysics, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cuoco+MS%22">Cuoco MS</searchLink>; Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Crowdis+J%22">Crowdis J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bosma-Moody+A%22">Bosma-Moody A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Z%22">Zhang Z</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, University of Massachusetts Memorial Medical Center, Worcester, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bi+K%22">Bi K</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kanodia+A%22">Kanodia A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Su+MJ%22">Su MJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ku+SY%22">Ku SY</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Garcia+MM%22">Garcia MM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sweet+AR%22">Sweet AR</searchLink>; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rodman+C%22">Rodman C</searchLink>; Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22DelloStritto+L%22">DelloStritto L</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Silver+R%22">Silver R</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Steinharter+J%22">Steinharter J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shah+P%22">Shah P</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Izar+B%22">Izar B</searchLink>; Columbia Center for Translational Immunology, New York, NY, USA.; Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Walk+NC%22">Walk NC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Burke+KP%22">Burke KP</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bakouny+Z%22">Bakouny Z</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tewari+AK%22">Tewari AK</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+D%22">Liu D</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Camp+SY%22">Camp SY</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Vokes+NI%22">Vokes NI</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Thoracic/Head and Neck Oncology, MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Salari+K%22">Salari K</searchLink>; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Urology, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Park+J%22">Park J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Vigneau+S%22">Vigneau S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fong+L%22">Fong L</searchLink>; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Russo+JW%22">Russo JW</searchLink>; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Yuan+X%22">Yuan X</searchLink>; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Balk+SP%22">Balk SP</searchLink>; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Beltran+H%22">Beltran H</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rozenblatt-Rosen+O%22">Rozenblatt-Rosen O</searchLink>; Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Regev+A%22">Regev A</searchLink>; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Biology, Howard Hughes Medical Institute and Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rotem+A%22">Rotem A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.; AstraZeneca, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Taplin+ME%22">Taplin ME</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Van+Allen+EM%22">Van Allen EM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu.; Broad Institute of Harvard and MIT, Cambridge, MA, USA. eliezerm_vanallen@dfci.harvard.edu.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2021 Mar; Vol. 27 (3), pp. 426-433. <i>Date of Electronic Publication: </i>2021 Mar 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33664492
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41591-021-01244-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 426
    Titles:
      – TitleFull: Transcriptional mediators of treatment resistance in lethal prostate cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: He MX
      – PersonEntity:
          Name:
            NameFull: Cuoco MS
      – PersonEntity:
          Name:
            NameFull: Crowdis J
      – PersonEntity:
          Name:
            NameFull: Bosma-Moody A
      – PersonEntity:
          Name:
            NameFull: Zhang Z
      – PersonEntity:
          Name:
            NameFull: Bi K
      – PersonEntity:
          Name:
            NameFull: Kanodia A
      – PersonEntity:
          Name:
            NameFull: Su MJ
      – PersonEntity:
          Name:
            NameFull: Ku SY
      – PersonEntity:
          Name:
            NameFull: Garcia MM
      – PersonEntity:
          Name:
            NameFull: Sweet AR
      – PersonEntity:
          Name:
            NameFull: Rodman C
      – PersonEntity:
          Name:
            NameFull: DelloStritto L
      – PersonEntity:
          Name:
            NameFull: Silver R
      – PersonEntity:
          Name:
            NameFull: Steinharter J
      – PersonEntity:
          Name:
            NameFull: Shah P
      – PersonEntity:
          Name:
            NameFull: Izar B
      – PersonEntity:
          Name:
            NameFull: Walk NC
      – PersonEntity:
          Name:
            NameFull: Burke KP
      – PersonEntity:
          Name:
            NameFull: Bakouny Z
      – PersonEntity:
          Name:
            NameFull: Tewari AK
      – PersonEntity:
          Name:
            NameFull: Liu D
      – PersonEntity:
          Name:
            NameFull: Camp SY
      – PersonEntity:
          Name:
            NameFull: Vokes NI
      – PersonEntity:
          Name:
            NameFull: Salari K
      – PersonEntity:
          Name:
            NameFull: Park J
      – PersonEntity:
          Name:
            NameFull: Vigneau S
      – PersonEntity:
          Name:
            NameFull: Fong L
      – PersonEntity:
          Name:
            NameFull: Russo JW
      – PersonEntity:
          Name:
            NameFull: Yuan X
      – PersonEntity:
          Name:
            NameFull: Balk SP
      – PersonEntity:
          Name:
            NameFull: Beltran H
      – PersonEntity:
          Name:
            NameFull: Rozenblatt-Rosen O
      – PersonEntity:
          Name:
            NameFull: Regev A
      – PersonEntity:
          Name:
            NameFull: Rotem A
      – PersonEntity:
          Name:
            NameFull: Taplin ME
      – PersonEntity:
          Name:
            NameFull: Van Allen EM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2021 Mar
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1